MarketPeel
Insider Trading Intelligence
Pricing
…
JG

Jennifer L. Good

RYTM
DIRECTOR · RHYTHM PHARMACEUTICALS, INC. · CIK 0001229245
FILING MIX · LIFETIME58%/42%
BUYS
45
SELLS
33
TOTAL VALUE
$6.19M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
677,324
AVG SELL PX
$25.49
TRADE KIND
SHOWING 78 / 78
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Jennifer L. Good, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+36.36%+2.68%+1.10%+1.58%+1.94%—
14d11+36.36%+3.42%+1.09%+2.34%+3.88%—
30d11+72.73%-2.69%+2.95%-5.65%-7.77%—
60d11+54.55%+2.72%+5.65%-2.93%-5.12%—
90d11+54.55%-1.25%+8.56%-9.82%-12.12%—
180d11+18.18%+23.87%+8.25%+15.62%+6.46%—
1y11+0.00%+121.56%+17.18%+104.38%+115.35%—
2y11(9 pending)+0.00%+423.41%+42.79%+380.62%+380.62%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RYTM · 2,324 shares · as of Jun 24, 2026
010,06020,12130,18140,241202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 45 buys / 33 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,324——2,324Jun 24, 2026Jun 25, 2026 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,691——3,691Jun 24, 2026Jun 25, 2026 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
4,712——11,712Jun 23, 2026Jun 25, 2026 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
4,712——0Jun 23, 2026Jun 25, 2026 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
675,000——675,000Feb 19, 2026Feb 20, 2026 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,037——7,037Jun 24, 2025Jun 26, 2025 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,712——4,712Jun 24, 2025Jun 26, 2025 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
4,000——7,000Jun 18, 2025Jun 23, 2025 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
4,000——0Jun 18, 2025Jun 23, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
102,000——156,400May 31, 2025Jun 3, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
5,263——0Mar 21, 2025Mar 25, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
5,263$1.43$7.5K218,576Mar 21, 2025Mar 25, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
5,263$6.58$34.6K213,313Mar 21, 2025Mar 25, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
54,400——54,400Mar 10, 2025Mar 12, 2025 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
811,000——811,000Feb 18, 2025Feb 20, 2025 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
7,501——0Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
15,000——0Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
31,751$52.40$1.66M3,000Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
7,501$18.99$142.4K34,751Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
9,250——0Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
15,000$22.93$343.9K18,000Sep 17, 2024Sep 19, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
9,250$21.37$197.7K27,250Sep 17, 2024Sep 19, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
1,840$3.04$5.6K213,313Sep 9, 2024Sep 9, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
1,840——0Sep 9, 2024Sep 9, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
1,840$1.43$2.6K215,153Sep 9, 2024Sep 9, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
4,305$21.37$92.0K20,205Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
12,900$22.93$295.8K15,900Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
18,300——0Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
37,241$50.45$1.88M3,000Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
1,736——7,501Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
1,736$18.99$33.0K21,941Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
12,900——15,000Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
4,305——9,250Sep 9, 2024Sep 11, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
18,300$4.15$75.9K40,241Sep 9, 2024Sep 11, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
4,219$3.03$12.8K213,313Sep 6, 2024Sep 9, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
4,219——1,840Sep 6, 2024Sep 9, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
4,219$1.43$6.0K217,532Sep 6, 2024Sep 9, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
40,277$1.43$57.6K253,590Sep 5, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
40,277——6,059Sep 5, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
40,277$3.11$125.3K213,313Sep 5, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
10,981$3.02$33.2K213,313Sep 4, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
10,981$1.43$15.7K224,294Sep 4, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
10,981——46,336Sep 4, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
3,863$1.43$5.5K217,176Sep 3, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
3,863$3.02$11.7K213,313Sep 3, 2024Sep 5, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
3,863——57,317Sep 3, 2024Sep 5, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
2,100——27,900Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
5,763——9,237Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
4,945$21.37$105.7K10,045Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
4,945——13,555Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
14,508$50.01$725.5K3,000Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
2,100$22.93$48.2K5,100Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
5,763$18.99$109.4K15,808Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
1,700——18,300Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
1,700$4.15$7.1K17,508Aug 26, 2024Aug 28, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
3,000——3,000Jun 21, 2024Jun 25, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
3,000——0Jun 21, 2024Jun 25, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Jun 18, 2024Jun 20, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,000——4,000Jun 18, 2024Jun 20, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
25,037——33,189May 20, 2024May 22, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
25,037$2.86$71.6K213,313May 20, 2024May 22, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
25,037$2.19$54.8K238,350May 20, 2024May 22, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
4,578——58,226May 10, 2024May 14, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
SALE
President & CEO
4,578$2.90$13.3K213,313May 10, 2024May 14, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASE
President & CEO
4,578$2.19$10.0K217,891May 10, 2024May 14, 2024 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
630,000——630,000Feb 15, 2024Feb 16, 2024 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Jun 21, 2023Jun 23, 2023 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Jun 21, 2023Jun 23, 2023 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
375,000——375,000Feb 16, 2023Feb 16, 2023 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,000——160,000Sep 19, 2022Sep 19, 2022 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
128,000——128,000Jun 29, 2022Jun 29, 2022 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jun 8, 2022Jun 10, 2022 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
275,000——275,000Feb 14, 2022Jul 1, 2022 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
275,000——275,000Feb 14, 2022Feb 15, 2022 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 9, 2021Jun 11, 2021 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000——160,000Feb 17, 2021Feb 19, 2021 ↗View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,500——18,500Jun 17, 2020Jun 18, 2020 ↗View →
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Feb 13, 2020Feb 18, 2020 ↗View →
Other insiders · RYTM
Loading peer insiders…
About this filer
CIK 0001229245
ROLE
Director
PRIMARY
RYTM
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001229245DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback